Clinical Overview > Condition/ Syndrome

You are looking at 1 - 1 of 1 items for :

  • AIP gene variant x
Clear All
Pia T Dinesen Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark

Search for other papers by Pia T Dinesen in
Google Scholar
PubMed
Close
,
Jakob Dal Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark

Search for other papers by Jakob Dal in
Google Scholar
PubMed
Close
,
Plamena Gabrovska Department of Endocrinology, Bart's and the London School of Medicine, Queen Mary University of London, London, UK

Search for other papers by Plamena Gabrovska in
Google Scholar
PubMed
Close
,
Mette Gaustadnes Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark

Search for other papers by Mette Gaustadnes in
Google Scholar
PubMed
Close
,
Claus H Gravholt Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark
Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark

Search for other papers by Claus H Gravholt in
Google Scholar
PubMed
Close
,
Karen Stals Department of Molecular Genetics, Royal Devon and Exeter, Foundation Trust, Exeter, UK

Search for other papers by Karen Stals in
Google Scholar
PubMed
Close
,
Judit Denes Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark

Search for other papers by Judit Denes in
Google Scholar
PubMed
Close
,
Sylvia L Asa Department of Pathology, University Health Network, Toronto, Ontario, Canada
Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada

Search for other papers by Sylvia L Asa in
Google Scholar
PubMed
Close
,
Márta Korbonits Department of Endocrinology, Bart's and the London School of Medicine, Queen Mary University of London, London, UK

Search for other papers by Márta Korbonits in
Google Scholar
PubMed
Close
, and
Jens O L Jørgensen Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark

Search for other papers by Jens O L Jørgensen in
Google Scholar
PubMed
Close

Summary

A patient of Cushing's disease (CD) characterized by a large tumor and only subtle symptoms of hormonal hypersecretion was examined. The patient had a germline variant in the aryl hydrocarbon receptor-interacting protein (AIP) gene. A 50-year-old male presenting with headache was diagnosed with a large pituitary tumor by magnetic resonance imaging (MRI). His visual fields were intact and he exhibited no features of CD. Owing to an exuberant response to synacthen, an overnight dexamethasone suppression test was performed revealing inadequate suppression of plasma cortisol (419 nmol/l). Owing to tumor growth and visual field impairment, he underwent transsphenoidal surgery and developed hypocortisolemia. The pathology specimen revealed a sparsely granulated corticotrope adenoma. Postoperative MRI showed a large tumor remnant. The patient developed skin hyperpigmentation and a synacthen test demonstrated high basal and stimulated cortisol levels; an overnight dexamethasone suppression test showed no suppression (791 nmol/l) and elevated plasma ACTH levels (135 ng/l). A transcranial operation was performed followed by radiotherapy. Two months after radiotherapy, he developed secondary adrenocortical failure. Genetic testing revealed an AIP variant of unknown significance (p.R16H) without loss of the normal AIP allele in the tumor. A literature review showed ten CD patients with AIP gene variants, of whom five (including our case) were p.R16H. CD is occasionally dominated by pituitary tumor growth rather than symptoms of hypersecretion. The particular AIP gene variant identified in our patient is shared by four other reported cases of CD. Future studies are needed to assess whether the reported AIP gene variant is more than just coincidental.

Learning points

  • CD is occasionally dominated by pituitary tumor growth rather than symptoms of hypersecretion.

  • Resolution of both tumor remnant and hormonal hypersecretion may occur within 2 months after postoperative radiotherapy.

  • The particular AIP gene variant identified in our patient is shared by four other reported cases of CD.

Open access